Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Immunomedics Inc (IMMU)

16.5 -0.2 (-1.2%)

04-20 16:00

Open:

16.64

Pre. Close:

16.7

High:

16.79

Low:

16.34

Volume:

810,115

Market Cap:

2735M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

16.807 - 16.899

16.899 - 16.975

Low:

16.117 - 16.232

16.232 - 16.327

Close:

16.327 - 16.502

16.502 - 16.648

Technical analysis  (as of: 2018-04-20 4:30:50 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 20.66     One year: 24.13

Support:

Support1: 15.30    Support2: 13.82

Resistance:

Resistance1: 17.69    Resistance2: 20.66

Pivot:

15.65

Moving Averages:

MA(5): 16.64     MA(20): 15.49

MA(100): 15.31     MA(250): 11.83

MACD:

MACD(12,26): 0.23     Signal(12,26,9):

%K %D:

%K(14,3): 79.08     %D(3): 84.37

RSI:

RSI(14): 55.21

52-Week:

High: 18.93  Low: 5.04  Change(%): 224.2

Average Vol(K):

3-Month: 198231  10-Days 164689

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
IMMU has closed below upper band by 29.2%. Bollinger Bands are 22.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-02-09T12:16:11-05:00
Immunomedics' (IMMU) Q2 2018 Results - Earnings Call Transcript

2018-02-08T16:18:02-05:00
Immunomedics beats by $0.10, misses on revenue

2018-01-13T11:32:09-05:00
InvestorsGuru.com 10 Filtered Mid-Day Market Movers Recap

2018-01-12T14:42:32-05:00
3 Things In Biotech You Should Learn Today: January 12, 2018

2018-01-12T14:20:22-05:00
Immunomedics (IMMU) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow

2018-01-12T08:00:00-05:00
3 Things In Biotech You Should Learn Today: January 11, 2018

2018-01-11T08:33:49-05:00
Immunomedics to fund mid-stage study of sacituzumab govitecan in CRPC

2018-01-10T09:15:19-05:00
When The Bulls Growl And The Bears Moo - Stock Market Outlook 2018

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

165.77

Shares Float (M)

164.53

% Held by Insiders

0.80

% Held by Institutions

78.20

Shares Short (K)

28375

Shares Short Prior Month (K)

23120

Stock Financials

EPS

-0.790

EPS Est. Current Year

-0.530

EPS Est. Next Year

-0.260

EPS Est. Next Quarter

-0.120

Forward EPS

-0.200

Book Value (p.s.)

156.090

PEG Ratio

Profit Margin

Operating Margin

-2857.88

Return on Assets (ttm)

-223.7

Return on Equity (ttm)

817.7

Qtrly Rev. Growth

55.5

Gross Profit (p.s.)

0.008

Sales Per Share

EBITDA (p.s.)

-1.021

Qtrly Earnings Growth

Operating Cash Flow (M)

-94.52

Levered Free Cash Flow (M)

25.10

atoplab.com

Valuation

P/E

-20.89

P/E Growth Ratio

-0.01

P/BV

0.11

P/S

91173502976.00

P/CF

-28.94

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.